|
C22ORF30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.273990E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.431000E-01 |
| Normal-vs-Stage2 |
2.828400E-01 |
| Normal-vs-Stage3 |
4.523300E-03 |
| Normal-vs-Stage4 |
2.735000E-03 |
| Stage1-vs-Stage2 |
3.082200E-01 |
| Stage1-vs-Stage3 |
9.967200E-04 |
| Stage1-vs-Stage4 |
6.191000E-04 |
| Stage2-vs-Stage3 |
1.801640E-01 |
| Stage2-vs-Stage4 |
1.351600E-01 |
| Stage3-vs-Stage4 |
8.053200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.423580E-01 |
| Normal-vs-AfricanAmerican |
1.257860E-02 |
| Normal-vs-Asian |
1.154390E-01 |
| Caucasian-vs-AfricanAmerican |
1.061610E-01 |
| Caucasian-vs-Asian |
4.500200E-02 |
| AfricanAmerican-vs-Asian |
1.435550E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.720100E-02 |
| Normal-vs-Female |
3.699000E-01 |
| Male-vs-Female |
2.122200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.957170E-01 |
| Normal-vs-Age(41-60Yrs) |
5.680800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.979700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.707900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.279400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.514600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.582400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.547900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.557600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.039380E-01 |
| Normal-vs-Grade 2 |
5.644800E-01 |
| Normal-vs-Grade 3 |
7.047800E-02 |
| Normal-vs-Grade 4 |
2.423100E-04 |
| Grade 1-vs-Grade 2 |
8.323800E-02 |
| Grade 1-vs-Grade 3 |
1.715850E-02 |
| Grade 1-vs-Grade 4 |
2.586100E-04 |
| Grade 2-vs-Grade 3 |
9.655700E-02 |
| Grade 2-vs-Grade 4 |
5.799900E-04 |
| Grade 3-vs-Grade 4 |
2.257900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.784600E-01 |
| Normal-vs-ccB subtype |
7.313500E-02 |
| ccA subtype-vs-ccB subtype |
3.924600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.105800E-01 |
| Normal-vs-N1 |
1.283830E-01 |
| N0-vs-N1 |
3.703400E-01 |
|
|
